Published in Cell on September 01, 1978
The human beta-globin gene contains multiple regulatory regions: identification of one promoter and two downstream enhancers. EMBO J (1988) 2.54
Linker scanning mutagenesis of the 5'-flanking region of the mouse beta-major-globin gene: sequence requirements for transcription in erythroid and nonerythroid cells. Mol Cell Biol (1985) 2.54
Localization of a unique gene by direct hybridization in situ. Proc Natl Acad Sci U S A (1981) 2.13
Clinical features and molecular analysis of the alpha thalassemia/mental retardation syndromes. II. Cases without detectable abnormality of the alpha globin complex. Am J Hum Genet (1990) 1.76
Assignment of human beta-, gamma-, and delta-globin genes to the short arm of chromosome 11 by chromosome sorting and DNA restriction enzyme analysis. Proc Natl Acad Sci U S A (1979) 1.67
Identification of a locus which shows no genetic recombination with the autosomal dominant polycystic kidney disease gene on chromosome 16. Am J Hum Genet (1990) 1.52
De novo truncation of chromosome 16p and healing with (TTAGGG)n in the alpha-thalassemia/mental retardation syndrome (ATR-16). Am J Hum Genet (1993) 1.46
DNA sequences involved in transcriptional regulation of the mouse beta-globin promoter in murine erythroleukemia cells. Mol Cell Biol (1988) 1.45
Discrimination among potential activators of the beta-globin CACCC element by correlation of binding and transcriptional properties. Mol Cell Biol (1993) 1.43
LCR/MEL: a versatile system for high-level expression of heterologous proteins in erythroid cells. Nucleic Acids Res (1992) 1.34
Initiation of transcription of the erythroid promoter of the porphobilinogen deaminase gene is regulated by a cis-acting sequence around the cap site. Nucleic Acids Res (1990) 1.32
GATA transcription factors associate with a novel class of nuclear bodies in erythroblasts and megakaryocytes. EMBO J (1996) 1.32
Enhanced translation and increased turnover of c-myc proteins occur during differentiation of murine erythroleukemia cells. Mol Cell Biol (1990) 1.27
Activation of human beta-globin genes from nonerythroid cells by fusion with murine erythroleukemia cells. Proc Natl Acad Sci U S A (1980) 1.26
Poly-L-ornithine-mediated transformation of mammalian cells. Mol Cell Biol (1987) 1.15
Cell type-specific protein-DNA interactions in the human zeta-globin upstream promoter region: displacement of Sp1 by the erythroid cell-specific factor NF-E1. Mol Cell Biol (1990) 1.13
Transcriptional promiscuity of the human alpha-globin gene. Mol Cell Biol (1989) 1.12
Activation of phenotypic expression of human globin genes from nonerythroid cells by chromosome-dependent transfer to tetraploid mouse erythroleukemia cells. Proc Natl Acad Sci U S A (1979) 1.10
A directly repeated sequence in the beta-globin promoter regulates transcription in murine erythroleukemia cells. Mol Cell Biol (1990) 1.01
DNA methylation and regulation of the human beta-globin-like genes in mouse erythroleukemia cells containing human chromosome 11. Proc Natl Acad Sci U S A (1984) 1.01
Expression of human myeloid-associated surface antigens in human-mouse myeloid cell hybrids. Proc Natl Acad Sci U S A (1983) 1.00
Effects of butyrate and glucocorticoids on gamma- to beta-globin gene switching in somatic cell hybrids. Mol Cell Biol (1995) 0.95
Adult and fetal human globin genes are expressed following chromosomal transfer into MEL cells. Proc Natl Acad Sci U S A (1985) 0.91
Expression of transfected vimentin genes in differentiating murine erythroleukemia cells reveals divergent cis-acting regulation of avian and mammalian vimentin sequences. Mol Cell Biol (1987) 0.89
Nuclear protein-binding sites in a transcriptional control region of the rabbit alpha-globin gene. Mol Cell Biol (1993) 0.89
A chromosome 11-linked determinant controls fetal globin expression and the fetal-to-adult globin switch. Proc Natl Acad Sci U S A (1987) 0.82
Transcriptional activation of human adult alpha-globin genes by hypersensitive site-40 enhancer: function of nuclear factor-binding motifs occupied in erythroid cells. Proc Natl Acad Sci U S A (1995) 0.82
CpG islands from the alpha-globin gene cluster increase gene expression in an integration-dependent manner. Mol Cell Biol (1997) 0.82
Beta-globin gene promoter generates 5' truncated transcripts in the embryonic/fetal erythroid environment. Nucleic Acids Res (1986) 0.81
Single domain intracellular antibodies from diverse libraries: emphasizing dual functions of LMO2 protein interactions using a single VH domain. J Biol Chem (2010) 0.81
Control of developmentally primed erythroid genes by combinatorial co-repressor actions. Nat Commun (2015) 0.80
Identification and characterization of a beta-globin promoter-binding factor from murine erythroleukemia cells. Mol Cell Biol (1993) 0.80
Uncovering enhancer functions using the α-globin locus. PLoS Genet (2014) 0.79
Differential regulation of the α-globin locus by Krüppel-like Factor 3 in erythroid and non-erythroid cells. BMC Mol Biol (2014) 0.76
v-abl activates embryonic globin gene expression in mouse erythroleukemia cells. Proc Natl Acad Sci U S A (1986) 0.75
Unspliced precursors of NMD-sensitive β-globin transcripts exhibit decreased steady-state levels in erythroid cells. PLoS One (2012) 0.75
Expression of human and mouse nonhistone chromosomal proteins in hybrid mouse erythroleukemia cells containing a single human chromosome. Proc Natl Acad Sci U S A (1981) 0.75
S1 nuclease analysis of alpha-globin gene expression in preleukemic patients with acquired hemoglobin H disease after transfer to mouse erythroleukemia cells. Proc Natl Acad Sci U S A (1987) 0.75
Localization of the human alpha-globin structural gene to chromosome 16 in somatic cell hybrids by molecular hybridization assay. Cell (1977) 4.34
Catalase: Physical and chemical properties, mechanism of catalysis, and physiological role. Physiol Rev (1970) 2.69
Chromosomal localization of human beta globin gene on human chromosome 11 in somatic cell hybrids. Proc Natl Acad Sci U S A (1978) 2.65
Preliminary results of treatment with filgrastim for relapse of leukemia and myelodysplasia after allogeneic bone marrow transplantation. N Engl J Med (1993) 2.09
Alteration of the cytotoxic action of sensitized lymphocytes by cholinergic agents and activators of adenylate cyclase. Proc Natl Acad Sci U S A (1972) 2.01
Effects of treatment with formoterol on bronchoprotection against methacholine. Am J Med (1998) 1.94
Standards of care for occupational asthma. Thorax (2007) 1.70
Cardiotoxicity associated with high-dose cyclophosphamide therapy. Arch Intern Med (1981) 1.43
Liposomal delivery of methylphosphonate antisense oligodeoxynucleotides in chronic myelogenous leukemia. Blood (1994) 1.41
Chronic myelogenous leukemia: a concise update. Blood (1993) 1.40
Expression of human alpha-globin genes in hybrid mouse erythroleukaemia cells depends on differentiated state of human donor cell. Nature (1980) 1.13
Activation of phenotypic expression of human globin genes from nonerythroid cells by chromosome-dependent transfer to tetraploid mouse erythroleukemia cells. Proc Natl Acad Sci U S A (1979) 1.10
Infra-His bundle origin of bidirectional tachycardia. Circulation (1973) 1.04
CD8-depleted donor lymphocyte infusion as treatment for relapsed chronic myelogenous leukemia after allogeneic bone marrow transplantation. Blood (1995) 1.03
Hemoglobin synthesis in somatic cell hybrids: coexpression of mouse with human or chinese hamster globin genes in interspecific somatic cell hybrids of mouse erythroleukemia cells. Proc Natl Acad Sci U S A (1975) 1.03
Hemoglobin synthesis in somatic cell hybrids: globin gene expression in hybrids between mouse erythroleukemia and human marrow cells or fibroblasts. Proc Natl Acad Sci U S A (1975) 1.03
Altered conformation of the p53 protein in myeloid leukemia cells and mitogen-stimulated normal blood cells. Oncogene (1992) 1.01
Mapping of angiogenic markers for targeting of vectors to tumor vascular endothelial cells. Cancer Gene Ther (2007) 1.00
Extinction of globin gene expression in human fibroblast x mouse erythroleukemia cell hybrids. Somatic Cell Genet (1976) 0.98
Rearrangement and expression of p53 in the chronic phase and blast crisis of chronic myelogenous leukemia. Blood (1990) 0.97
An isoform of protein disulfide isomerase isolated from chronic myelogenous leukemia cells alters complex formation between nuclear proteins and regulatory regions of interferon-inducible genes. J Biol Chem (1992) 0.96
Enrichment for the globin coding region in a chromatin fraction from chick reticulocytes by endonuclease digestion. Gene (1977) 0.95
Polymorphism at codon 72 of the p53 gene in human acute myelogenous leukemia. Gene (1992) 0.93
Improvement of PCR sequencing by formamide. Nucleic Acids Res (1991) 0.93
Hemoglobin synthesis in somatic cell hybrids: independent segregation of the human alpha- and beta-globin genes. Science (1976) 0.92
Regulatory factors specific for adult and embryonic globin genes may govern their expression in erythroleukemia cells. Blood (1985) 0.91
Inactive p53 mutants may enhance the transcriptional activity of wild-type p53. Cancer Res (1993) 0.91
Phase I trial of an interleukin-2 (IL-2) fusion toxin (DAB486IL-2) in hematologic malignancies expressing the IL-2 receptor. Blood (1992) 0.88
Characterization of an unique RNA initiated immediately upstream from human alpha 1 globin gene in vivo and in vitro: polymerase II-dependence, tissue specificity, and subcellular location. Nucleic Acids Res (1985) 0.87
Study of markers of human erythroid differentiation in hybrid cells. In Vitro (1976) 0.87
Messenger ribonucleoprotein-directed globin synthesis in an embryonic brain cell-free system. Biochim Biophys Acta (1974) 0.86
Detection of minimal residual disease by polymerase chain reaction in Philadelphia chromosome-positive chronic myelogenous leukemia following interferon therapy. Blood (1992) 0.84
The role of autologous stem cell reconstitution in intensive therapy for resistant neoplasms. Cancer Treat Rep (1979) 0.84
Polyclonal hematopoiesis in interferon-induced cytogenetic remissions of chronic myelogenous leukemia. Blood (1992) 0.83
Regulatory role of the cyclic nucleotides in alloimmune lymphocyte mediated cytotoxicity. Effect of imidazole. Transplant Proc (1973) 0.83
Engineering conditionally replication-competent adenoviral vectors carrying the cytosine deaminase gene increases the infectivity and therapeutic effect for breast cancer gene therapy. Cancer Gene Ther (2006) 0.83
The use of the L-plastin promoter for adenoviral-mediated, tumor-specific gene expression in ovarian and bladder cancer cell lines. Cancer Res (2001) 0.83
Oncolytic adenoviral vector carrying the cytosine deaminase gene for melanoma gene therapy. Cancer Gene Ther (2006) 0.83
The effect of filtration on absolute and differential cell counts in fluid obtained at bronchoalveolar lavage. Respir Med (1989) 0.82
Autologous transplants for chronic myelogenous leukaemia: results from eight transplant groups. Lancet (1994) 0.82
A phase I study of paclitaxel for mobilization of peripheral blood progenitor cells. Bone Marrow Transplant (1999) 0.82
Early metabolic response to tumor necrosis factor in mouse sarcoma: a phosphorus-31 nuclear magnetic resonance study. Cancer Res (1989) 0.81
Metabolic disposition and toxicity of 6-mercaptopurine after massive overdose. Lancet (1984) 0.81
Prognostic value of proliferating cell nuclear antigen expression in chronic lymphoid leukemia. Blood (1992) 0.81
Regression of canine mammary carcinoma after immunoadsorption therapy. Cancer Res (1982) 0.80
Results of retroviral and adenoviral approaches to cancer gene therapy. Stem Cells (1998) 0.80
Metabolic studies of histones and residual protein of rat liver nuclei. Arch Biochem Biophys (1968) 0.79
The effect of bronchoalveolar lavage on bronchial responsiveness in patients with airflow obstruction. Chest (1988) 0.79
Detection of minimal residual disease by polymerase chain reaction of bcr/abl transcripts in chronic myelogenous leukaemia following allogeneic bone marrow transplantation. Br J Haematol (1992) 0.78
Liposomal delivery of oligodeoxynucleotides. Leuk Lymphoma (1996) 0.78
Chicken globin gene number. Nucleic Acids Res (1976) 0.78
Tumor-specific therapeutic effect induced by an oncolytic adenoviral vector containing heat shock protein 70 and prodrug activation genes. Gene Ther (2006) 0.78
Differentiation of carcinomatous and bacterial meningitis. Neurology (1972) 0.78
DNAase I nuclease digestion studies of the human zeta globin gene before and after transfer from the K562 cell to the mouse erythroleukemia cell. Prog Clin Biol Res (1987) 0.77
Evidence for multiple sites of regulation of heme synthesis in murine erythroleukemia cells. J Natl Cancer Inst (1979) 0.77
A phosphatase activity present in peripheral blood myeloid cells of chronic myelogenous leukemia patients but not normal individuals alters nuclear protein binding to transcriptional enhancers of interferon-inducible genes. J Clin Invest (1990) 0.77
Treatment of chronic myelogenous leukemia in accelerated and blastic phases with daunorubicin, high-dose cytarabine, and granulocyte-macrophage colony-stimulating factor. J Clin Oncol (1992) 0.76
Long-range amplification of genomic DNA detects the t(2;5)(p23;q35) in anaplastic large-cell lymphoma, but not in other non-Hodgkin's lymphomas, Hodgkin's disease, or lymphomatoid papulosis. Ann Oncol (1997) 0.76
Chemotherapy immediately following autologous stem-cell transplantation in patients with advanced breast cancer. Clin Cancer Res (1998) 0.76
The purification and crystallization of beef erythrocyte catalase. Arch Biochem Biophys (1969) 0.76
Antagonistic effects of ABL and BCRABL proteins on proliferation and the response to genotoxic stress in normal and leukemic myeloid cells. Leuk Lymphoma (1998) 0.76
S1 nuclease analysis of alpha-globin gene expression in preleukemic patients with acquired hemoglobin H disease after transfer to mouse erythroleukemia cells. Proc Natl Acad Sci U S A (1987) 0.75
Cellular and molecular studies on globin gene expression. Natl Cancer Inst Monogr (1978) 0.75
Adenoviral vectors and hematopoietic cells. Blood (1997) 0.75
Proliferation of hematopoietic cells is accompanied by suppressed expression of heat shock protein 70. Biochem Biophys Res Commun (1992) 0.75
Expression of human and mouse nonhistone chromosomal proteins in hybrid mouse erythroleukemia cells containing a single human chromosome. Proc Natl Acad Sci U S A (1981) 0.75
CD2 expression and the PML-RAR gene. Blood (1993) 0.75
Platelet phosphorylase activity in the presence of activators and inhibitors of aggregation. Biochem Biophys Res Commun (1970) 0.75
Biological characterization of stem cell present in mobilized peripheral blood of CML patients. Bone Marrow Transplant (1994) 0.75
Genetic therapy using bone marrow transplantation. Cancer Treat Res (1995) 0.75
Methods for Chemoprotection and Chemosensitization : MDR-1 For Chemoprotection Using Retroviruses to Modify Hematopoietic Cells and Cytosine Deaminase for Chemosensitization Using Adenoviral Vectors to Modify Epithelian Neoplastic Cells. Methods Mol Med (2000) 0.75
Prospects for eradication of therapy-induced myelosuppression. Bone Marrow Transplant (1990) 0.75
5' region of zeta-globin and GMCSF genes share binding site for nuclear proteins. Trans Assoc Am Physicians (1988) 0.75
Chronic myelogenous leukemia--update and future directions. Rev Invest Clin (1994) 0.75
Autologous stem cell reconstitution and the intensive therapy of resistant solid tumors in man. Exp Hematol (1979) 0.75
Quinidine-induced liver disease. Ann Intern Med (1972) 0.75
Identification of a complex formed between nuclear proteins and the transcriptional enhancer of interferon-inducible genes that is present in the peripheral blood myeloid cells of CML but not normal individuals. J Interferon Res (1992) 0.75
Platelet phosphorylase activity in the presence of activators and inhibitors of aggregation. Biochem Biophys Res Commun (1970) 0.75
The phosphorylation of retinoblastoma gene product in human myeloid leukemia cells during the cell cycle. Biochem Biophys Res Commun (1992) 0.75
Isolation of hybrid cell clones that contain deletion and non-deletion defects of alpha-thalassemia in man. Blood (1980) 0.75
Laboratory findings in pulmonary embolism. Ann Intern Med (1971) 0.75
Systemic treatment of malignant melanoma. Clin Plast Surg (2000) 0.75
Sensitization of prostate cancer cell lines to 5-fluorocytosine induced by adenoviral vector carrying a CD transcription unit. Chin Med J (Engl) (2001) 0.75
Use of recombinant human hematopoietic growth factors and autologous bone marrow transplantation to attenuate the neutropenic trough of high-dose therapy. Int J Cell Cloning (1990) 0.75
Molecular approaches to purging of chronic myelogenous leukemia marrow in autologous transplantation. Prog Clin Biol Res (1992) 0.75
Treatment of poor-prognosis, newly diagnosed acute myelogenous leukemia with high-dose cytosine arabinoside (Ara-C) and rHUGM-CSF. Haematol Blood Transfus (1990) 0.75
The first intron of human h-ras is regulated by p53 - mediation of specific activation by a p53-binding element. Int J Oncol (1995) 0.75
Translation of rabbit and avian globin messenger RNA in an Ehrlich ascites cell-free system: species differences of ribosomal wash factors. Hoppe Seylers Z Physiol Chem (1975) 0.75
Isolation of hybrid cells that exhibit markers of erythroid differentiation. N Engl J Med (1976) 0.75
Selective isolation of young erythrocytes for transfusion support of thalassemia major patients. Blood (1981) 0.75
Phase I trial of Staphylococcus aureus Cowan I immunoperfusion. Cancer Treat Rep (1982) 0.75
Chromosomal localization and regional mapping of the human globin genes. Tex Rep Biol Med (1982) 0.75
Identification of proteins binding to interferon-inducible transcriptional enhancers in hematopoietic cells. J Biol Chem (1992) 0.75
The use of Protein-A in the treatment of malignancy: rationale and the NCI experience. Prog Clin Biol Res (1982) 0.75